Yanyang Lu Selected Research

Non-alcoholic Fatty Liver Disease

5/2019	MicroRNA-26a-CD36 signaling pathway: Pivotal role in lipid accumulation in hepatocytes induced by PM2.5 liposoluble extracts.
2/2019	Gut microbiota dysbiosis correlates with a low-dose PCB126-induced dyslipidemia and non-alcoholic fatty liver disease.
9/2017	Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanyang Lu Research Topics

Disease

3	Non-alcoholic Fatty Liver Disease 05/2019 - 09/2017
2	Inflammation (Inflammations) 05/2019 - 01/2017
2	Dysbiosis 02/2019 - 01/2019
1	Memory Disorders (Memory Loss) 04/2024
1	Cognitive Dysfunction 04/2024
1	Primary Ovarian Insufficiency 01/2023
1	Dyslipidemias (Dyslipidemia) 02/2019
1	Body Weight (Weight, Body) 02/2019
1	Obesity 01/2019
1	Hyperlipidemias (Hyperlipidemia) 01/2019
1	Immune System Diseases (Immune Disorders) 01/2019
1	Insulin Resistance 09/2017
1	Pathologic Processes 01/2017

Drug/Important Bio-Agent (IBA)

4	LipidsIBA 05/2019 - 09/2017
1	NMDA receptor A1IBA 04/2024
1	metabotropic glutamate receptor type 1IBA 04/2024
1	ArsenicIBA 04/2024
1	3,4,5,3',4'-pentachlorobiphenylIBA 02/2019
1	bisphenol AIBA 09/2017
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2017
1	Long Noncoding RNAIBA 01/2017
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2017

Therapy/Procedure

1	Therapeutics 01/2023